Free Trial
NASDAQ:IMCC

IM Cannabis Q2 2025 Earnings Report

IM Cannabis logo
$2.57 -0.03 (-1.15%)
Closing price 08/13/2025 03:59 PM Eastern
Extended Trading
$2.80 +0.23 (+8.95%)
As of 04:46 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

IM Cannabis EPS Results

Actual EPS
-$0.07
Consensus EPS
-$0.14
Beat/Miss
Beat by +$0.07
One Year Ago EPS
N/A

IM Cannabis Revenue Results

Actual Revenue
$9.21 million
Expected Revenue
$12.88 million
Beat/Miss
Missed by -$3.67 million
YoY Revenue Growth
N/A

IM Cannabis Announcement Details

Quarter
Q2 2025
Time
Before Market Opens
Conference Call Date
Tuesday, August 12, 2025
Conference Call Time
9:00AM ET

Earnings Documents

IM Cannabis Earnings Headlines

IM Cannabis Reports Second Quarter 2025 Financial Results
New law could create $3.7 trillion tsunami.
During a meeting in Washington D.C., Jeff Brown discovered a bold initiative. He calls it “President Trump’s Project MAFA,” and it could soon return America to a “new” gold standard. The Trump administration, Wall Street, and Silicon Valley are all pushing it forward. The President himself calls the plan “incredible.” Already, it’s helping small plays jump as high as 300%, 318%, 520%, and even 600%.
See More IM Cannabis Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like IM Cannabis? Sign up for Earnings360's daily newsletter to receive timely earnings updates on IM Cannabis and other key companies, straight to your email.

About IM Cannabis

IM Cannabis (NASDAQ:IMCC) engages in breeding, growing, and supply of medical cannabis products in Israel and Germany. It offers cannabis flowers and strain-specific cannabis extracts under the IMC brand; and dried flower, pre-rolls, minis, and full spectrum extracts offerings under the WAGNERS and BLKMKT brands. The company serves medical patients. IM Cannabis Corp. is headquartered in Tel Aviv, Israel.

View IM Cannabis Profile

More Earnings Resources from MarketBeat